Tempest Therapeutics
TPST
#10230
Rank
A$21.5 M
Marketcap
A$4.36
Share price
-2.34%
Change (1 day)
-75.05%
Change (1 year)

Earnings for Tempest Therapeutics (TPST)

Earnings in 2025 (TTM): -A$56.16 Million

According to Tempest Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$60.58 Million a decrease over its 2023 earnings that were of -A$41.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Tempest Therapeutics from 2021 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$56.16 Million-7.3%
2024 -A$60.58 Million44.52%
2023 -A$41.92 Million-17.74%
2022 -A$50.96 Million26.17%
2021 -A$40.39 Million